CBD can be used safely in women with advanced breast cancer and clinical anxiety

This Phase II trial explores CBD for anxiety in breast cancer patients, indicating safety and potential anxiolytic effects despite no primary outcome success.

Worse Outcomes After Esophagectomy at Private Equity-Owned Hospitals

Esophagectomy outcomes trended in the wrong direction at hospitals owned by private-equity companies, a review of more than 9,000 cases showed. Statistically significant differences existed

January 3, 2025

Psychedelic Bulletin #142: Terran’s IP Portfolio; AMA Advocates Against Non-Medical Psychedelics; Couple Receives First Psilocybin Services in Oregon; Mass. Ballot Measure Ramps Up; NIDA and NIMH Directors Opine – Psychedelic Alpha

The Directors of the National Institute on Drug Abuse (NIDA) and National Institute of Mental Health (NIMH)—billion dollar government research agencies—shared their thoughts on the

July 31, 2023

FDA approves Verrica’s skin infection treatment, enters into non-binding term sheet for $125M loan

Verrica Pharmaceuticals’ drug-device combination product is now the first FDA-approved treatment for molluscum contagiosum, a common skin infection. On Friday the FDA approved Ycanth, a

July 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.